Twenty years ago, there was a shift in pain management, and it became more common to prescribe opioids for chronic pain. Initially, physicians were misinformed that addiction to these medications was highly unlikely in a clinical setting, causing a shift towards prescribing opioids as the drug class of choice to treat moderate-to-severe pain. At the time, the addictive properties of opioids and their lack of proven effectiveness for treating chronic pain were not fully recognized.
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
Our team is always happy to hear from you. Please call us at:
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now: